CD18 (beta 2 Leukocyte Integrin) Promoter Requires PU.1 Transcription Factor for Myeloid Activity

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1995 Jan 31

PMID 7846055

Citations 17

Authors

A G Rosmarin

D Caprio

R Levy

C Simkevich

Affiliations

Soon will be listed here.

Abstract

Normal cellular differentiation is linked to tightly regulated gene transcription. However, the DNA elements and trans-acting factors that regulate transcription in myeloid cells are poorly defined. CD18, the beta chain of the leukocyte integrins, is transcriptionally regulated during myeloid differentiation. The CD18 promoter is active after transfection into myeloid cells. We demonstrate that a region of the CD18 promoter that contains two binding sites for the PU.1 transcription factor is required for activity in myeloid cells. These sites are bound by in vitro translated PU.1 and by PU.1 from myeloid nuclear extracts. Mutagenesis of these sites abrogates binding by PU.1 and substantially decreases promoter activity in myeloid cells. Thus, the leukocyte-specific transcription factor PU.1 is required for myeloid activity of CD18.

Citing Articles

Using a Network-Based Analysis Approach to Investigate the Involvement of in the Pathogenesis of Granulomatosis with Polyangiitis.

Rowland G, Kronbichler A, Smith R, Jayne D, van der Graaf P, Chelliah V Int J Mol Sci. 2023; 24(3).

PMID: 36768148 PMC: 9915048. DOI: 10.3390/ijms24031822.

KDM6A Lysine Demethylase Directs Epigenetic Polarity of MDSCs during Murine Sepsis.

Bah I, Alkhateeb T, Youssef D, Yao Z, McCall C, El Gazzar M J Innate Immun. 2021; 14(2):112-123.

PMID: 34289476 PMC: 9082193. DOI: 10.1159/000517407.

Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Abdel-Azim H, Sun W, Wu L Pharmacol Ther. 2019; 204:107403.

PMID: 31470030 PMC: 6881549. DOI: 10.1016/j.pharmthera.2019.107403.

Substrate stiffness influences phenotype and function of human antigen-presenting dendritic cells.

Mennens S, Bolomini-Vittori M, Weiden J, Joosten B, Cambi A, van den Dries K Sci Rep. 2017; 7(1):17511.

PMID: 29235514 PMC: 5727489. DOI: 10.1038/s41598-017-17787-z.

IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Khawar M, Mukhtar M, Abbasi M, Sheikh N Am J Transl Res. 2017; 9(11):4726-4737.

PMID: 29218075 PMC: 5714761.

References

Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View

Henikoff S . Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene. 1984; 28(3):351-9. DOI: 10.1016/0378-1119(84)90153-7. View

Galson D, Housman D . Detection of two tissue-specific DNA-binding proteins with affinity for sites in the mouse beta-globin intervening sequence 2. Mol Cell Biol. 1988; 8(1):381-92. PMC: 363134. DOI: 10.1128/mcb.8.1.381-392.1988. View

Todd 3rd R, Freyer D . The CD11/CD18 leukocyte glycoprotein deficiency. Hematol Oncol Clin North Am. 1988; 2(1):13-31. View

Rosmarin A, Weil S, Rosner G, Griffin J, Arnaout M, Tenen D . Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation. Blood. 1989; 73(1):131-6. View

Mitchell P, Tjian R . Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 1989; 245(4916):371-8. DOI: 10.1126/science.2667136. View

Hohn P, Popescu N, Hanson R, Salvesen G, Ley T . Genomic organization and chromosomal localization of the human cathepsin G gene. J Biol Chem. 1989; 264(23):13412-9. View

Klemsz M, McKercher S, Celada A, Van Beveren C, Maki R . The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell. 1990; 61(1):113-24. DOI: 10.1016/0092-8674(90)90219-5. View

Pahl H, Rosmarin A, Tenen D . Characterization of the myeloid-specific CD11b promoter. Blood. 1992; 79(4):865-70. View

10.

Dalton S, Treisman R . Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell. 1992; 68(3):597-612. DOI: 10.1016/0092-8674(92)90194-h. View

11.

Rosmarin A, Levy R, Tenen D . Cloning and analysis of the CD18 promoter. Blood. 1992; 79(10):2598-604. View

12.

Ray D, BOSSELUT R, Ghysdael J, Mattei M, Tavitian A, Moreau-Gachelin F . Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol Cell Biol. 1992; 12(10):4297-304. PMC: 360353. DOI: 10.1128/mcb.12.10.4297-4304.1992. View

13.

Pahl H, Scheibe R, Zhang D, Chen H, Galson D, Maki R . The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem. 1993; 268(7):5014-20. View

14.

Pongubala J, Van Beveren C, Nagulapalli S, Klemsz M, McKercher S, Maki R . Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science. 1993; 259(5101):1622-5. DOI: 10.1126/science.8456286. View

15.

Chen H, Pahl H, Scheibe R, Zhang D, Tenen D . The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity. J Biol Chem. 1993; 268(11):8230-9. View

16.

Brown T, McKnight S . Specificities of protein-protein and protein-DNA interaction of GABP alpha and two newly defined ets-related proteins. Genes Dev. 1992; 6(12B):2502-12. DOI: 10.1101/gad.6.12b.2502. View

17.

Zhang D, Hetherington C, Chen H, Tenen D . The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol. 1994; 14(1):373-81. PMC: 358386. DOI: 10.1128/mcb.14.1.373-381.1994. View

18.

Bottinger E, Shelley C, Farokhzad O, Arnaout M . The human beta 2 integrin CD18 promoter consists of two inverted Ets cis elements. Mol Cell Biol. 1994; 14(4):2604-15. PMC: 358628. DOI: 10.1128/mcb.14.4.2604-2615.1994. View

19.

Voso M, Burn T, Wulf G, Lim B, Leone G, Tenen D . Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Proc Natl Acad Sci U S A. 1994; 91(17):7932-6. PMC: 44518. DOI: 10.1073/pnas.91.17.7932. View

20.

Scott E, Simon M, Anastasi J, Singh H . Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994; 265(5178):1573-7. DOI: 10.1126/science.8079170. View